Latest It Distribution News

Rhythm Biosciences has inked a non-exclusive distribution agreement with 4Cyte Pathology to integrate its ColoSTAT® colorectal cancer blood test into a vast pathology network across eastern Australia, aiming to boost adoption and accessibility.

Deterra Royalties Limited has announced a fully franked ordinary dividend of AUD 0.124 per share for the half-year ending December 2025, accompanied by a Dividend Reinvestment Plan offering shareholders a no-discount option to reinvest.

Iceni Gold has reported anomalous copper, zinc, and lead in its deepest drill hole at the Welcome Creek Project, signalling promising mineralisation in the Officer Basin. While the main geophysical target remains untested due to drill deviation, the findings open new avenues for exploration.

Prominence Energy has begun preparatory work for its first geochemical survey in South Australia's PEL 803, aiming to detect natural hydrogen and helium as part of the Gawler Hydrogen Project.

Red Hill Minerals highlights a strong dividend-paying model backed by diversified royalties and a vigorous 2026 exploration agenda at the RIU Explorers Conference.

Vita Resources has unveiled a commissioned re-evaluation of its ICE Copper-Gold Project in Yukon, revealing significant silver, cobalt, and indium mineralisation that upgrades the project to polymetallic status. This fresh insight sets the stage for expanded exploration and resource assessment.

Macmahon Holdings has reported a robust first half of FY26, delivering double-digit growth in revenue and earnings alongside a significant dividend increase and reaffirmed full-year guidance.

RWC’s H1 FY26 results reveal a 4.6% sales decline and a 22.5% drop in adjusted EBITDA, largely due to US tariffs and regional market pressures. The company is countering challenges by opening a new manufacturing facility in Mexico and expects modest sales recovery in H2 FY26.

Reliance Worldwide Corporation reported a 4.6% revenue decline and a 34.9% drop in net profit for H1 FY2026, citing US tariffs and weaker demand in key markets. The company balances challenges with cost savings and a shareholder-friendly capital return strategy.

HealthCo Healthcare & Wellness REIT reported resilient 1H FY26 results despite suspending distributions amid ongoing Healthscope challenges, underpinned by a diversified $1.4 billion healthcare real estate portfolio and strategic lease agreements.

HealthCo Healthcare & Wellness REIT posted solid half-year results amid ongoing efforts to resolve the Healthscope hospital portfolio situation, maintaining strong operational metrics and capital discipline.

HealthCo Healthcare and Wellness REIT posted a $26.8 million net loss for the half-year ended December 2025, driven by asset sales and fair value declines. The REIT suspended distributions and reduced its property portfolio as it navigates tenant risks and debt refinancing.